Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-824
Closed -$230K 186
2025
Q2
$230K Hold
824
0.04% 165
2025
Q1
$257K Hold
824
0.05% 150
2024
Q4
$215K Sell
824
-19
-2% -$5.64K 0.04% 166
2024
Q3
$272K Sell
843
-58
-6% -$19K 0.06% 159
2024
Q2
$282K Hold
901
0.06% 149
2024
Q1
$256K Hold
901
0.07% 125
2023
Q4
$260K Sell
901
-174
-16% -$47.4K 0.07% 141
2023
Q3
$289K Buy
+1,075
New +$268K 0.08% 128
2023
Q2
Sell
-861
Closed -$208K 181
2023
Q1
$208K Buy
861
+74
+9% +$18.2K 0.07% 146
2022
Q4
$207K Buy
+787
New +$211K 0.07% 135

Other funds holding AMGN

LJI Wealth Management's AMGN Position: Q3 2025 in Review

LJI Wealth Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 824 shares — an estimated $230K sold.

LJI Wealth Management first reported a position in AMGN in Q4 2022 and held it in 10 quarters. The position peaked at $289K in Q3 2023. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • LJI Wealth Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • LJI Wealth Management sold 824 Amgen shares in Q3 2025, an estimated $230K.
  • LJI Wealth Management first reported a position in Amgen in Q4 2022 and held it in 10 quarters.
  • LJI Wealth Management's Amgen position peaked at $289K in Q3 2023.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on LJI Wealth Management's 13F filing for Q3 2025, filed 29 Oct 2025.